Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance
- PMID: 19942086
- DOI: 10.1016/j.jacc.2009.08.024
Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance
Abstract
Objectives: We investigated the extent and nature of myocardial damage by using cardiovascular magnetic resonance (CMR) in relation to different time-to-reperfusion intervals.
Background: Previous studies evaluating the influence of time to reperfusion on infarct size (IS) and myocardial salvage in patients with ST-segment elevation myocardial infarction (STEMI) have yielded conflicting results.
Methods: Seventy patients with STEMI successfully treated with primary percutaneous coronary intervention within 12 h from symptom onset underwent CMR 3 +/- 2 days after hospital admission. Patients were subcategorized into 4 time-to-reperfusion (symptom onset to balloon) quartiles: < or =90 min (group I, n = 19), >90 to 150 min (group II, n = 17), >150 to 360 min (group III, n = 17), and >360 min (group IV, n = 17). T2-weighted short tau inversion recovery and late gadolinium enhancement CMR were used to characterize reversible and irreversible myocardial injury (area at risk and IS, respectively); salvaged myocardium was defined as the normalized difference between extent of T2-weighted short tau inversion recovery and late gadolinium enhancement.
Results: Shorter time-to-reperfusion (group I) was associated with smaller IS and microvascular obstruction and larger salvaged myocardium. Mean IS progressively increased overtime: 8% (group I), 11.7% (group II), 12.7% (group III), and 17.9% (group IV), p = 0.017; similarly, MVO was larger in patients reperfused later (0.5%, 1.5%, 3.7%, and 6.6%, respectively, p = 0.047). Accordingly, salvaged myocardium markedly decreased when reperfusion occurred >90 min of coronary occlusion (8.5%, 3.2%, 2.4%, and 2.1%, respectively, p = 0.004).
Conclusions: In patients with STEMI treated with primary percutaneous coronary intervention, time to reperfusion determines the extent of reversible and irreversible myocardial injury assessed by CMR. In particular, salvaged myocardium is markedly reduced when reperfusion occurs >90 min of coronary occlusion.
Comment in
-
Ischemic time: the new gold standard for ST-segment elevation myocardial infarction care.J Am Coll Cardiol. 2009 Dec 1;54(23):2154-6. doi: 10.1016/j.jacc.2009.08.023. J Am Coll Cardiol. 2009. PMID: 19942087 No abstract available.
Similar articles
-
Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".Herz. 2008 Mar;33(2):136-42. doi: 10.1007/s00059-008-3102-8. Herz. 2008. PMID: 18344033
-
Association of Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade with cardiovascular magnetic resonance measures of infarct architecture after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.Am Heart J. 2009 Jul;158(1):84-91. doi: 10.1016/j.ahj.2009.04.012. Am Heart J. 2009. PMID: 19540396
-
Late gadolinium-enhanced cardiovascular magnetic resonance evaluation of infarct size and microvascular obstruction in optimally treated patients after acute myocardial infarction.J Cardiovasc Magn Reson. 2007;9(5):765-70. doi: 10.1080/10976640701545008. J Cardiovasc Magn Reson. 2007. PMID: 17891613
-
Microvascular dysfunction following primary percutaneous coronary intervention in the setting of ST-elevation myocardial infarction.J Invasive Cardiol. 2008 Nov;20(11):603-14. J Invasive Cardiol. 2008. PMID: 18987402 Review.
-
Myocardial no-reflow in humans.J Am Coll Cardiol. 2009 Jul 21;54(4):281-92. doi: 10.1016/j.jacc.2009.03.054. J Am Coll Cardiol. 2009. PMID: 19608025 Review.
Cited by
-
Regional disparities in mortality after ischemic heart disease in a Brazilian state from 2006 to 2010.PLoS One. 2013;8(3):e59363. doi: 10.1371/journal.pone.0059363. Epub 2013 Mar 19. PLoS One. 2013. PMID: 23527174 Free PMC article.
-
First Human Use of RUC-4: A Nonactivating Second-Generation Small-Molecule Platelet Glycoprotein IIb/IIIa (Integrin αIIbβ3) Inhibitor Designed for Subcutaneous Point-of-Care Treatment of ST-Segment-Elevation Myocardial Infarction.J Am Heart Assoc. 2020 Sep;9(17):e016552. doi: 10.1161/JAHA.120.016552. Epub 2020 Aug 26. J Am Heart Assoc. 2020. PMID: 32844723 Free PMC article. Clinical Trial.
-
Microvascular obstruction extent predicts major adverse cardiovascular events in patients with acute myocardial infarction and preserved ejection fraction.Eur Radiol. 2019 May;29(5):2369-2377. doi: 10.1007/s00330-018-5895-z. Epub 2018 Dec 14. Eur Radiol. 2019. PMID: 30552479
-
Interpretation of acute myocardial infarction with persistent 'hyperacute T waves' by cardiac magnetic resonance.Eur Heart J Acute Cardiovasc Care. 2012 Dec;1(4):344-8. doi: 10.1177/2048872612466537. Eur Heart J Acute Cardiovasc Care. 2012. PMID: 24062926 Free PMC article.
-
Outcome of primary PCI - an Indian tertiary care center experience.Indian Heart J. 2014 Jan-Feb;66(1):25-30. doi: 10.1016/j.ihj.2013.12.036. Epub 2014 Jan 3. Indian Heart J. 2014. PMID: 24581092 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical